| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |